Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation

Marty, FM; Ljungman, P; Chemaly, RF; Maertens, J; Dadwal, SS; Duarte, RF; Haider, S; Ullmann, AJ; Katayama, Y; Brown, J; Mullane, KM; Boeckh, M; Blumberg, EA; Einsele, H; Snydman, DR; Kanda, Y; DiNubile, MJ; Teal, VL; Wan, H; Murata, Y; Kartsonis, NA

Marty, FM (reprint author), Brigham & Womens Hosp, Div Infect Dis, 75 Francis St, Boston, MA 02115 USA.

NEW ENGLAND JOURNAL OF MEDICINE, 2017; 377 (25): 2433

Abstract

BACKGROUND Cytomegalovirus (CMV) infection remains a common complication after allogeneic hematopoietic-cell transplantation. Letermovir is an antivir......

Full Text Link